TY - JOUR
T1 - Biphasic cortical macro- and microstructural changes in autosomal dominant Alzheimer's disease
AU - for the Dominantly Inherited Alzheimer Network (DIAN)
AU - Montal, Victor
AU - Vilaplana, Eduard
AU - Pegueroles, Jordi
AU - Bejanin, Alexandre
AU - Alcolea, Daniel
AU - Carmona-Iragui, María
AU - Clarimón, Jordi
AU - Levin, Johannes
AU - Cruchaga, Carlos
AU - Graff-Radford, Neill R.
AU - Noble, James M.
AU - Lee, Jae Hong
AU - Allegri, Ricardo
AU - Karch, Celeste M.
AU - Laske, Christoph
AU - Schofield, Peter R.
AU - Salloway, Stephen
AU - Ances, Beau
AU - Benzinger, Tammie
AU - McDale, Eric
AU - Bateman, Randall
AU - Blesa, Rafael
AU - Sánchez-Valle, Raquel
AU - Lleó, Alberto
AU - Fortea, Juan
N1 - Funding Information:
We acknowledge the altruism of the participants and their families and contributions of the DIAN research and support staff at each of the participating sites for their contributions to this study. Data collection and sharing for this project was supported by The Dominantly Inherited Alzheimer's Network (DIAN, UF1AG032438) funded by the National Institute on Aging (NIA), the German Center for Neurodegenerative Diseases (DZNE), and Raul Carrea Institute for Neurological Research (FLENI), with partial support by the Research and Development Grants for Dementia from Japan Agency for Medical Research and Development, AMED, and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI). This article has been reviewed by DIAN Study investigators for scientific content and consistency of data interpretation with previous DIAN Study publications. In addition, this project was founded by the Fondo de Investigaciones Sanitario (FIS), Instituto de Salud Carlos III (PI14/01126 and PI17/01019 to JF, PI13/01532 and PI16/01825 to RB, PI18/00335 to MCI, PI18/00435 and INT19/00016 to DA, PI14/1561, PI16/0235 to RSV and PI17/01896 to AL) and the CIBERNED program (Program 1, Alzheimer Disease to Alberto Lleó and SIGNAL study, www.signalstudy.es ), partially jointly funded by Fondo Europeo de Desarrollo Regional, Unión Europea, Una manera de hacer Europa. This work was also supported by the National Institutes of Health (NIA grants 1R01AG056850 ‐ 01A1; R21AG056974 and R01AG061566 to JF), Departament de Salut de la Generalitat de Catalunya, Pla Estratègic de Recerca i Innovació en Salut (SLT002/16/00408 to AL), Fundació La Marató de TV3 (20141210 to JF, 044412 to RB); V. Montal is supported by Fondo de Investigaciones Sanitario (FI18/00275). A Bejanin was a recipient of Juan de la Cierva‐Incorporación grant from the Spanish Ministry of Economy and Competitiveness (IJCI‐2017‐32609). This work was also supported by Generalitat de Catalunya (SLT006/17/00119 to JF, SLT006/17/95 to EV and SLT006/17/00125 to DA) and a grant from the Fundació Bancaria La Caixa to RB.
Publisher Copyright:
© 2020 the Alzheimer's Association
PY - 2021/4
Y1 - 2021/4
N2 - INTRODUCTION: A biphasic model for brain structural changes in preclinical Alzheimer's disease (AD) could reconcile some conflicting and paradoxical findings in observational studies and anti-amyloid clinical trials. METHODS: In this study we tested this model fitting linear versus quadratic trajectories and computed the timing of the inflection points vertexwise of cortical thickness and cortical diffusivity—a novel marker of cortical microstructure—changes in 389 participants from the Dominantly Inherited Alzheimer Network. RESULTS: In early preclinical AD, between 20 and 15 years before estimated symptom onset, we found increases in cortical thickness and decreases in cortical diffusivity followed by cortical thinning and cortical diffusivity increases in later preclinical and symptomatic stages. The inflection points 16 to 19 years before estimated symptom onset are in agreement with the start of tau biomarker alterations. DISCUSSION: These findings confirm a biphasic trajectory for brain structural changes and have direct implications when interpreting magnetic resonance imaging measures in preventive AD clinical trials.
AB - INTRODUCTION: A biphasic model for brain structural changes in preclinical Alzheimer's disease (AD) could reconcile some conflicting and paradoxical findings in observational studies and anti-amyloid clinical trials. METHODS: In this study we tested this model fitting linear versus quadratic trajectories and computed the timing of the inflection points vertexwise of cortical thickness and cortical diffusivity—a novel marker of cortical microstructure—changes in 389 participants from the Dominantly Inherited Alzheimer Network. RESULTS: In early preclinical AD, between 20 and 15 years before estimated symptom onset, we found increases in cortical thickness and decreases in cortical diffusivity followed by cortical thinning and cortical diffusivity increases in later preclinical and symptomatic stages. The inflection points 16 to 19 years before estimated symptom onset are in agreement with the start of tau biomarker alterations. DISCUSSION: These findings confirm a biphasic trajectory for brain structural changes and have direct implications when interpreting magnetic resonance imaging measures in preventive AD clinical trials.
KW - Alzheimer's disease
KW - autosomal-dominant Alzheimer's disease
KW - biphasic cortical changes
KW - cortical diffusivity
KW - magnetic resonance imaging
KW - preclinical Alzheimer's disease
UR - http://www.scopus.com/inward/record.url?scp=85096946684&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096946684&partnerID=8YFLogxK
U2 - 10.1002/alz.12224
DO - 10.1002/alz.12224
M3 - Article
AN - SCOPUS:85096946684
SN - 1552-5260
VL - 17
SP - 618
EP - 628
JO - Alzheimer's and Dementia
JF - Alzheimer's and Dementia
IS - 4
ER -